News about Global Pharma

LIC Sells Over Two per cent Stake in Sun Pharma for Rs 4,699 Cr

LIC has sold two per cent of its holding in Sun Pharma for Rs 4,699 crore via open market sale.

Global Pharma | 19/09/2023 | By Manvi |  670

Blue Star Industrial Solutions Partners with Gebhardt Intralogistics Group for Warehouse Automation Solutions

Blue Star Industrial Solutions specialises in quality testing and automation offerings and the collaboration with Gebhardt further strengthens its capabilities.

Global Pharma | 19/09/2023 | By Manvi |  706

Insud Pharma Opens its Oligonucleotides Centre in Genome Valley

This is the first-of-its-kind research and production centre in India focused on Oligonucleotides research and commercial production. It also ranks among the top five globally, alongside brand companies, with a focus on the U.S., European Union and numerous global markets.

Global Pharma | 19/09/2023 | By Manvi |  949

Waaree Group Celebrates Exceptional Growth by Offering One-Time Bonuses to All Employees

The one-time bonus have been granted to team members who joined the company on or before April 1st, 2022, and continued to be part of its journey throughout the entire financial year, concluding on 31st March, 2023.

Global Pharma | 15/09/2023 | By Manvi |  988

Astellas Lays Out Plans to Build USD 354 Million Manufacturing Facility in Ireland

Astellas is doubling down on its already significant presence in Ireland, revealing plans to invest 330 million euros ($354 million) in a new manufacturing facility in the Kerry Technology Park in Tralee.

Global Pharma | 15/09/2023 | By Manvi |  1387

Bajaj Healthcare Receives EIR from USFDA for API Manufacturing Facility in Savli

BHL has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations (No inspectional observations).

Global Pharma | 15/09/2023 | By Manvi |  1398

Rentschler Biopharma's ATMP UK Facility Receives MHRA Approval

Following the successful MHRA inspection, Rentschler Biopharma’s ATMP business can now offer its full range of services for the clinical supply of AAV, including bioprocess and analytical development through to cGMP manufacturing at their Stevenage facility in the UK.

Global Pharma | 15/09/2023 | By Manvi |  694

Renaissance Lakewood Expands New Jersey Lab Facilities

The facilities upgrade began in 2021 and consists of the relocation of existing labs from other parts of the Renaissance campus nearby to a new, 31,000-sq.-ft. science building and office space.

Global Pharma | 15/09/2023 | By Manvi |  1256

Zydus Gets EIR for Injectables Manufacturing Facility at Zydus Biotech Park, Ahmedabad

The inspection was a cGMP Inspection and had ended with NIL observations.

Global Pharma | 15/09/2023 | By Manvi |  702

Nitika Pharmaceuticals to Inaugurate Microcrystalline Cellulose Manufacturing Plant in Nagpur

Nitika Pharmaceuticals Specialties to unveil India’s largest Microcrystalline Cellulose manufacturing plant. This event will be graced by two distinguished leaders, Nitin Gadkari and Devendra Fadnavis.

Global Pharma | 13/09/2023 | By Manvi |  1430